EP3267881A1 - Agencement d'affichage pour le diagnostic de troubles de rythme cardiaque - Google Patents
Agencement d'affichage pour le diagnostic de troubles de rythme cardiaqueInfo
- Publication number
- EP3267881A1 EP3267881A1 EP16712606.9A EP16712606A EP3267881A1 EP 3267881 A1 EP3267881 A1 EP 3267881A1 EP 16712606 A EP16712606 A EP 16712606A EP 3267881 A1 EP3267881 A1 EP 3267881A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- ecg
- plot
- accordance
- interval
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000747 cardiac effect Effects 0.000 title claims abstract description 61
- 230000033764 rhythmic process Effects 0.000 title claims abstract description 60
- 238000003745 diagnosis Methods 0.000 title claims description 42
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 29
- 206010003658 Atrial Fibrillation Diseases 0.000 claims description 25
- 230000002123 temporal effect Effects 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 24
- 238000012544 monitoring process Methods 0.000 claims description 22
- 230000000694 effects Effects 0.000 claims description 18
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 12
- 230000036982 action potential Effects 0.000 claims description 10
- 238000002560 therapeutic procedure Methods 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 230000036772 blood pressure Effects 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 230000036387 respiratory rate Effects 0.000 claims description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 6
- 239000001569 carbon dioxide Substances 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 6
- 210000004072 lung Anatomy 0.000 claims description 6
- 206010042772 syncope Diseases 0.000 claims description 6
- 210000000038 chest Anatomy 0.000 claims description 4
- 210000001562 sternum Anatomy 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 3
- 238000004364 calculation method Methods 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims 3
- 206010003119 arrhythmia Diseases 0.000 abstract description 9
- 230000000007 visual effect Effects 0.000 abstract description 7
- 230000006793 arrhythmia Effects 0.000 abstract description 6
- 230000004069 differentiation Effects 0.000 abstract description 3
- 239000002131 composite material Substances 0.000 description 39
- 208000035475 disorder Diseases 0.000 description 26
- 238000010586 diagram Methods 0.000 description 24
- 206010003662 Atrial flutter Diseases 0.000 description 19
- 230000001746 atrial effect Effects 0.000 description 8
- 206010042602 Supraventricular extrasystoles Diseases 0.000 description 6
- 208000007888 Sinus Tachycardia Diseases 0.000 description 5
- 208000006218 bradycardia Diseases 0.000 description 5
- 230000036471 bradycardia Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000001788 irregular Effects 0.000 description 5
- 230000035479 physiological effects, processes and functions Effects 0.000 description 5
- 230000002861 ventricular Effects 0.000 description 5
- 206010015856 Extrasystoles Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000001447 compensatory effect Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000002565 electrocardiography Methods 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000028161 membrane depolarization Effects 0.000 description 3
- 238000000718 qrs complex Methods 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 206010040741 Sinus bradycardia Diseases 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 206010047289 Ventricular extrasystoles Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000001992 atrioventricular node Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000004213 regulation of atrial cardiomyocyte membrane depolarization Effects 0.000 description 2
- 230000034225 regulation of ventricular cardiomyocyte membrane depolarization Effects 0.000 description 2
- 230000013577 regulation of ventricular cardiomyocyte membrane repolarization Effects 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000006794 tachycardia Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 208000001193 Accelerated Idioventricular Rhythm Diseases 0.000 description 1
- 208000000730 Ectopic Atrial Tachycardia Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010029470 Nodal rhythm Diseases 0.000 description 1
- 206010040736 Sinoatrial block Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 201000008803 Wolff-Parkinson-white syndrome Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000004375 bundle of his Anatomy 0.000 description 1
- 230000002802 cardiorespiratory effect Effects 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 210000003742 purkinje fiber Anatomy 0.000 description 1
- 238000000306 qrs interval Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000024977 response to activity Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/0245—Detecting, measuring or recording pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/339—Displays specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/361—Detecting fibrillation
Definitions
- This application relates in general to electrocardiographic monitoring and, in particular, to a method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer.
- An electrocardiogram allows physicians to diagnose cardiac function by visually tracing the cutaneous electrical signals (action potentials) that are generated by the propagation of the transmembrane ionic currents that trigger the depolarization of cardiac fibers.
- An ECG trace contains alphabetically-labeled waveform deflections that represent distinct features within the cyclic cardiac activation sequence.
- the P-wave represents atrial depolarization, which causes atrial contraction.
- the QRS-complex represents ventricular depolarization.
- the T-wave represents ventricular repolarization.
- the R-wave is often used as an abbreviation for the QRS-complex.
- An R-R interval spans the period between successive R-waves and, in a normal heart, is 600 milliseconds (ms) to one second long, which respectively correspond to 100 to 60 beats per minute (bpm).
- the R-wave is the largest waveform generated during normal conduction and represents the cardiac electrical stimuli passing through the ventricular walls.
- R-R intervals provide information that allows a physician to understand at a glance the context of cardiac rhythms both before and after a suspected rhythm abnormality and can be of confirmational and collaborative value in cardiac arrhythmia diagnosis and treatment.
- ECGs are less than ideal tools for diagnosing cardiac arrhythmia patterns that only become apparent over an extended time frame, such as 30 minutes or longer.
- R-R intervals have also been visualized in Poincare plots, which graph RR( «) on the x- axis and RR( « + 1) on the_y-axis.
- a Poincare plot fails to preserve the correlation between an R-R interval and the R-R interval's time of occurrence and the linearity of time and associated contextual information, before and after a specific cardiac rhythm, are lost.
- R-R interval data is presented to physicians in a format that includes views of relevant near field and far field ECG data, which together provide contextual information that improves diagnostic accuracy.
- the near field (or short duration) ECG data view provides a "pinpoint" classical view of an ECG at traditional recording speed in a manner that is known to and widely embraced by physicians.
- the near field ECG data is coupled to a far field (or medium duration) ECG data view that provides an "intermediate" lower resolution, pre- and post-event contextual view.
- Both near field and far field ECG data views are temporally keyed to an extended duration R-R interval data view.
- the R-R interval data view is scaled non- linearly to maximize the visual differentiation for frequently-occurring heart rate ranges, such that a single glance allows the physician to make a diagnosis. All three views are presented simultaneously, thereby allowing an interpreting physician to diagnose rhythm and the pre- and post-contextual events leading up to a cardiac rhythm of interest.
- the durations of the classical "pinpoint” view, the pre- and post-event “intermediate” view, and the R-R interval plot are flexible and adjustable.
- a temporal point of reference is identified in the R-R interval plot and the ECG data that is temporally associated with the point of reference is displayed in the near field and far field ECG data views.
- diagnostically relevant cardiac events can be identified as the temporal point of reference.
- the temporal point of reference will generally be placed in the center of the R-R interval data to allow pre- and post-event heart rhythm and ECG waveform data to present in the correct context.
- intermediate views of ECG data with the extended term R-R interval data allow a physician to comparatively view heart rate context and patterns of behavior prior to and after a clinically meaningful arrhythmia, patient concern or other indicia, thereby enhancing diagnostic specificity of cardiac rhythm disorders and providing physiological context to improve diagnostic ability.
- One embodiment provides a system and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer.
- Cutaneous action potentials of a patient are monitored and recorded.
- the cutaneous action potentials are retrieved as electrocardiogram (ECG) data for a set time period and a plurality of R-wave peaks in the ECG data are identified.
- a difference between recording times of successive pairs of the R-wave peaks is calculated and a heart rate associated with each time difference is determined.
- An extended duration R-R interval plot over the set time period is formed and includes each of the recording time differences and the associated heart rates.
- the extended duration R-R interval plot is displayed and a temporal point of reference in the extended duration R-R interval plot is identified. At least part of the ECG data preceding and following the temporal point of reference is displayed as context in at least one accompanying ECG plot.
- the foregoing aspects enhance the presentation of diagnostically relevant R-R interval data, reduce time and effort needed to gather relevant information by a clinician and provide the clinician with a concise and effective diagnostic tool, which is critical to accurate arrhythmia and cardiac rhythm disorder diagnoses.
- Custom software packages have been used to identify diagnostically relevant cardiac events from the electrocardiography data, but usually require a cardiologist's diagnosis and verification.
- the foregoing approach aids the cardiologist's diagnostic job by facilitating presentation of ECG-based background information prior to and after the identified event.
- FIGURE 1 is a graph showing, by way of example, a single ECG waveform.
- FIGURE 2 is a graph showing, by way of example, a prior art Poincare R-R interval plot.
- FIGURE 3 is a flow diagram showing a method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer in accordance with one embodiment.
- FIGURE 4 is a flow diagram showing a routine for constructing and displaying a diagnostic composite plot for use in the method of FIGURE 3.
- FIGURE 5 is a flow diagram showing a routine for constructing an extended-duration R-R interval plot for use in the routine of FIGURE 4.
- FIGURE 6 is a diagram showing, by way of example, a diagnostic composite plot generated by the method of FIGURE 3.
- FIGURE 7 is a diagram showing, by way of example, a diagnostic composite plot for facilitating the diagnosis of sinus rhythm (SR) transitioning into atrial fibrillation (AF).
- SR sinus rhythm
- AF atrial fibrillation
- FIGURE 8 is a diagram showing, by way of example, a diagnostic composite plot for facilitating the diagnosis of 3 : 1 atrial flutter (AFL) transitioning into SR.
- AFL atrial flutter
- FIGURE 9 is a diagram showing, by way of example, a diagnostic composite plot for facilitating the diagnosis of atrial trigeminy.
- FIGURE 10 is a diagram showing, by way of example, a diagnostic composite plot for facilitating the diagnosis of maximum heart rate in an episode of AF during exercise.
- FIGURE 11 is a diagram showing, by way of example, a diagnostic composite plot for facilitating the diagnosis of SR transitioning into AFL transitioning into AF.
- FIGURE 12 is a diagram showing, by way of example, a diagnostic composite plot for facilitating the diagnosis of sinus tachycardia and palpitations that occurred during exercise accompanied by a jump in heart rate.
- FIGURE 13 is a diagram showing, by way of example, a diagnostic composite plot for facilitating the diagnosis of bradycardia.
- FIGURE 14 is a block diagram showing a system for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer in accordance with one embodiment.
- a normal healthy cardiac cycle repeats through an expected sequence of events that can be visually traced through an ECG.
- Each cycle starts with cardiac depolarization originating high in the right atrium in the sinoatrial (SA) node before spreading leftward towards the left atrium and inferiorly towards the atrioventricular (AV) node.
- SA sinoatrial
- AV atrioventricular
- the depolarization impulse transits the Bundle of His and moves into the right and left bundle branches and Purkinje fibers to activate the right and left ventricles.
- FIGURE 1 is a graph showing, by way of example, a single ECG waveform 10.
- the x-axis represents approximate time in units of tenths of a second and the_y-axis represents approximate cutaneous electrical signal strength in units of millivolts.
- ECGs are typically printed or displayed at an effective paper speed of 25 millimeters (mm) per second.
- an ECG may be provided to a physician in traditional paper-printed form, in "virtual" electronic display form, or both, the term “effective paper speed” is nevertheless still widely applied as a metric to normalize the recorded ECG signal to a standardized grid of 1 mm squares (omitted for the sake of clarity in FIGURE 1), whereby each 1 mm horizontal box in the grid corresponds to 0.04 s (40 ms) of recorded time.
- Other effective paper speeds, grid sizes and units of display are possible.
- a full ECG consists of a stream of alphabetically-labeled waveforms 10 that collectively cover cardiac performance over a period of observation.
- the P-wave 11 will normally have a smooth, normally upward, positive waveform that indicates atrial depolarization.
- the QRS complex 17 will usually follow, often with a downward deflection of a Q-wave 12, followed by a larger upward deflection of an R-wave 13, and be terminated with a downward waveform of the S-wave 14, which are collectively representative of ventricular depolarization.
- the T-wave 15 will normally be a modest upward waveform, representative of ventricular repolarization, while the U-wave 16, which is often not directly observable, will indicate the recovery period of the Purkinje conduction fibers.
- AF atrial fibrillation
- ECG R- R interval the pattern formed by R-R intervals over an extended time period
- AF is the chaotic firing of the atria that leads to an erratic activation of the ventricles.
- AF is initially diagnosed by an absence of organized P-waves 11 and confirmed by erratic ventricular rates that manifest in an ECG R- R interval plot as a cloud-like pattern of irregular R-R intervals due to an abnormal conduction of impulses to the ventricles.
- Gaussian-like distribution to these R-R intervals during AF.
- Atrial flutter is an abnormal heart rhythm in which cardiac impulses travel along pathways within the right atrium in an organized circular motion, causing the atria to beat faster than and out of sync with the ventricles. During AFL, the heart beats quickly, yet with a regular pattern.
- AFL presents in an electrogram (e-gram) as a "sawtooth" pattern
- e-gram electrogram
- R-R interval patterns that usually manifest as 2: 1 atrioventricular (AV) conduction or 4: 1 atrioventricular conduction.
- the conduction through the AV node is variable and not fixed.
- FIGURE 2 is a graph showing, by way of example, a prior art Poincare R-R interval plot 18.
- the x-axis represents the duration of R-R interval n in units of milliseconds (ms).
- The_y-axis represents the duration of R-R interval n + 1 also in units of ms.
- the x- and_y-axes use the same units, so as to form a trend line 19 along the 45-degree angle.
- the dot representing the two intervals falls onto the 45-degree trend line 19.
- the dot representing the two intervals falls off the 45-degree trend line 19 and, as the difference between successive R-R intervals increases, the dots fall further away from the trend line 19.
- the number of dots deviating from the trend line 19 in a Poincare plot can indicate the frequency of occurrence of irregular heartbeats when compared to the number of dots on the trend line 19.
- the distance of the dots to the trend line 19 can approximate the extent of heart rate change from one heartbeat to the next.
- heart rate change is limited to only successively-occurring heartbeats, the linearity of time and associated contextual information over an extended time frame are lost.
- significant changes in heart rate particularly spikes in heart rate, such as due to sinus rhythm transitions to atrial flutter, may be masked, distorted or even omitted in a Poincare plot if the change occurs over non-successive heartbeats.
- a Poincare plot is more useful as a mathematical tool than a physiological one, and therefore a Poincare plot cannot truly represent what the heart is doing serially over time with respect to changes in the heart's normal and abnormal physiology.
- R-R interval data when presented in a format duplicating temporal physiological events remains a key tool that physicians can rely upon to identify temporally-related cardiac dysrhythmic patterns.
- Interpretation of R-R interval data can be assisted by including multiple temporal points of reference and a plot of R-R interval data that comparatively depicts heart rate variability in concert with R-R interval data.
- FIGURE 3 is a flow diagram showing a method 20 for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer in accordance with one embodiment.
- the method 20 can be implemented in software and execution of the software can be performed on a computer, such as further described infra with reference to FIGURE 14, as a series of process or method modules or steps.
- ECG recordation As a precursor step, the cutaneous action potentials of a patient are monitored and recorded as ECG data over a set time period (step 21), which can be over a short term or extended time frame.
- ECG recordation can be provided through various kinds of ECG-capable monitoring ensembles, including a standardized 12-lead ECG setup, such as used for clinical ECG monitoring, a portable Holter-type ECG recorder for traditional ambulatory ECG monitoring, or a wearable ambulatory ECG monitor, such as a flexible extended wear electrode patch and a removable reusable (or single use) monitor recorder, such as described in commonly-assigned U.S.
- Patent application entitled “Method for Providing Dynamic Gain over Electrocardiographic Data with the aid of a Digital Computer,” Serial No. 14/997,416, filed January 15, 2016, pending, the disclosure of which is incorporated by reference, the latter of which includes an electrode patch and monitor recorder that are synergistically optimized to capture electrical signals from the propagation of low amplitude, relatively low frequency content cardiac action potentials, particularly the P-waves, generated during atrial activation. Still other forms of ECG monitoring assembles are possible.
- the ECG and any physiological data are downloaded or retrieved into a digital computer, as further described infra with reference to FIGURE 14, with, for instance, the assistance of a download station or similar device, or via wireless connection, if so equipped, and a vector of the downloaded or retrieved ECG data is obtained (step 22).
- the vector of ECG data represents a 40-minute (or other duration) time span that is used in constructing the plot of R-R interval data, although other pre-event and post-event time spans are possible.
- a potentially-actionable cardiac event within the vector of ECG data can be identified and the ECG data during, prior to and after the event is selected (step 23).
- the event could be identified with the assistance of a software package, such as Holter LX Analysis Software, licensed by NorthEast Monitoring, Inc., Maynard, MA; IntelliSpace Cardiovascular Image and Information management system, licensed Koninklijke Philips N.V., Amsterdam, Netherlands; MoMe System, licensed by InfoBionic, Lowell, MA; Pyramis ECG Management, licensed by Mortara Instrument Inc., Milwaukee, WI; ICS Clinical Suite, licensed by Spacelabs Healthcare Inc., Snoqualmie, WA; or a customized software package.
- a software package such as Holter LX Analysis Software, licensed by NorthEast Monitoring, Inc., Maynard, MA; IntelliSpace Cardiovascular Image and Information management system, licensed Koninklijke Philips N.V., Amsterdam, Netherlands; MoMe System, licensed by InfoBionic, Lowell, MA; Pyramis ECG Management, licensed by Mortara Instrument Inc., Milwaukee, WI; ICS Clinical Suite, licensed by Spacelabs Healthcare Inc., Snoqualmie, WA; or a customized software package.
- both near field and far field contextual views of the ECG data are constructed and displayed. Both views are temporally keyed to an extended duration R-R interval data view that, in one embodiment, is scaled non-linearly to maximize the visual differentiation for frequently-occurring heart rate ranges, such that a single glance allows the physician to make a diagnosis. All three views are presented simultaneously, thereby allowing the interpreting physician to diagnose rhythm and the pre- and post-contextual events leading up to a cardiac rhythm of interest.
- findings made through interpretation of heart rate variability patterns in the diagnostic composite plot can be analyzed to form a diagnosis of a cardiac rhythm disorder (step 25), such as the cardiac rhythm disorders listed, by way of example, in Table 1.
- a cardiac rhythm disorder such as the cardiac rhythm disorders listed, by way of example, in Table 1.
- the heart rate variability patterns in the diagnostic composite plot could be provided to a system that programmatically detects AF by virtue of looking for the classic Gaussian-type distribution on the "cloud" of heart rate variability formed in the plot of R-R interval data, which can be corroborated by the accompanying contextual ECG data.
- a cardiac rhythm therapy delivery device such as an implantable medical device (FMD) (not shown), including a pacemaker, implantable cardioverter defibrillator (ICD), or similar devices.
- FMD implantable medical device
- ICD implantable cardioverter defibrillator
- a diagnostic composite plot is constructed and displayed to help physicians identify and diagnose temporally-related cardiac dysrhythmic patterns.
- the diagnostic composite plot includes ECG traces from two or more temporal points of reference and a plot of R-R interval data, although other configurations of ECG data plots when combined with the R-R interval plot will also provide critical information.
- FIGURE 4 is a flow diagram showing a routine 30 for constructing and displaying a diagnostic composite plot for use in the method 20 of FIGURE 3. Specific examples of diagnostic composite plots are discussed in detail infra with reference to FIGURES 7-13.
- R-R interval data is presented to physicians in a format that includes views of relevant near field and far field ECG data, which together provide contextual information that improves diagnostic accuracy.
- the near field (or short duration) ECG data provides a "pinpoint" classical view of an ECG at traditional recording speed in a manner that is known to and widely embraced by physicians.
- the near field ECG data is coupled to a far field (or medium duration) ECG data view that provides an "intermediate" lower resolution, pre- and post-event contextual view.
- the extended-duration R-R interval plot is first constructed (step 31), as further described infra with reference to FIGURE 5.
- noise can be filtered from the R-R interval plot (step 32), which is then displayed (step 33).
- Noise filtering can include low-pass or high-pass filtering or other forms of signal processing, including automatic gain control, such as described in commonly-assigned U.S. Patent application, Serial No. 14/997,416, cited supra.
- Rhythm disorders have different weightings depending upon the context with which they occur.
- the R-R interval data view and the multiple views of the ECG data provide that necessary context.
- the short and medium duration ECG data that accompanies the extended-duration R-R interval plot represents the ECG data "zoomed” in around a temporal point of reference identified in the center (or other location) of the R-R interval plot, thereby providing a visual context to the physician that allows temporal assessment of cardiac rhythm changes in various complementary views of the heart's behavior.
- the durations of the classical "pinpoint" view, the pre- and post-event “intermediate” view, and the R-R interval plot are flexible and adjustable.
- the diagnostic composite plot displays R-R interval data over a forty -minute duration and ECG data over short and medium durations (steps 34 and 35), such as four-second and 24-second durations that provide two- and 12-second segments of the ECG data before and after the R-R interval plot's temporal point of reference, which is generally in the center of the R-R interval plot, although other locations in the R-R interval plot could be identified as the temporal point of reference.
- the pinpoint "snapshot" and intermediate views of ECG data with the extended term R-R interval data comparatively depicts heart rate context and patterns of behavior prior to and after a clinically meaningful arrhythmia or patient concern, thereby enhancing diagnostic specificity of cardiac rhythm disorders and providing physiological context to improve diagnostic ability.
- diagnostically relevant cardiac events can be identified and the R-R interval plot can be constructed with a cardiac event centered in the middle (or other location) of the plot, which thereby allows pre- and post-event heart rhythm data to be contextually "framed" through the pinpoint and intermediate ECG data views.
- Other durations, intervals and presentations of ECG data are possible.
- the extended-duration R-R interval plot presents beat-to-beat heart rate variability in a format that is intuitive and contextual, yet condensed.
- the format of the R-R interval plot is selected to optimize visualization of cardiac events in a compressed, yet understandable field of view, that allows for compact presentation of the data akin to a cardiologists understanding of clinical events.
- FIGURE 5 is a flow diagram showing a routine 40 for constructing an extended-duration R-R interval plot for use in the routine 30 of FIGURE 4.
- the duration of the R-R interval plot can vary from less than one minute to the entire duration of the recording.
- a plurality of R-wave peaks is first selected out of the vector of ECG data (step 41) appropriate to the duration of the R-R interval plot to be constructed.
- each recording time difference represents the length of one heartbeat.
- the heart rate associated with the recording time difference is determined by taking an inverse of the recording time difference and normalizing the inverse to beats per minute (step 44). Taking the inverse of the recording time difference yields a heart rate expressed in beats per second, which can be adjusted by a factor of 60 to provide a heart rate expressed in bpm.
- R-R intervals and associated heart rates are formed into a two- dimensional plot.
- R-R intervals are plotted along the x-axis and associated heart rates are plotted along the _y-axis.
- the range and scale of the_y-axis can be adjusted according to the range and frequency of normal or patient-specific heart rates, so as to increase the visual distinctions between the heart rates that correspond to different R-R intervals.
- the_y-axis of the R-R interval plot has a range of 20 to 300 beats per minute and R-R intervals corresponding to heart rates falling extremely outside of this range are excluded to allow easy visualization of 99+% of the heart rate possibilities.
- the_y-axis has a non-linear scale that is calculated as a function of the x-axis (R-R interval), such that: where x is the time difference, min bpm is the minimum heart rate, max bpm is the maximum heart rate, and n ⁇ ⁇ .
- the overall effect is to accentuate the spatial differences in frequently-occurring ranges of heart rate and de-emphasize the spatial differential in ranges of heart rate where a deviation from norm would have been apparent, thus maximizing the spatial efficiency in data presentation.
- the goal is to show cardiac events in a simple, small visual contextual format. Larger scales and larger formats bely the practical limits of single-page presentations for the easy visualization at a glance by the busy physician.
- the visual distinctions between the heart rates that correspond to different R-R intervals stand out, especially when plotted on a nonlinear scale. Others-axis ranges and scales are possible as may be selected by distinct clinical needs and specific diagnostic requirements.
- the diagnostic composite plot includes a single, long range view of R-R interval data and a pair of pinpoint ECG data views that together help to facilitate rhythm disorder diagnosis by placing focused long-term heart rate information alongside short-term and medium-term ECG information.
- Such pairing of ECG and R-R interval data is unique in its ability to inform the physician of events prior to, during and after a cardiovascular event.
- FIGURE 6 is a diagram showing, by way of example, a diagnostic composite plot 50 generated by the method 30 of FIGURE 3. Note that the diagnostic composite plot can be tailored to include more than one view of R-R interval data and as many views of contextual ECG data as needed.
- a background information plot presenting an extended far field of related information can be included, such as activity amount, activity intensity, posture, syncope impulse detection, respiratory rate, blood pressure, oxygen saturation (Sp0 2 ), blood carbon dioxide level (pC0 2 ), glucose, lung wetness, and temperature.
- Other forms of background information are possible.
- background information can be layered on top of or keyed to the diagnostic composite plot 50, particularly at key points of time in the R-R interval data plot, so that the context provided by each item of background information can be readily accessed by the reviewing physician.
- the diagnostic composite plot 50 includes an ECG plot presenting a near field (short duration) view 51, an ECG plot presenting an intermediate field (medium duration) view 52, and an R-R interval data plot presenting a far field (extended duration) view 53.
- the three views 51, 52, 53 are juxtaposed alongside one other to allow quick back and forth referencing of the full context of the heart's normal and abnormal physiology.
- a temporal point of reference which could be a diagnostically relevant cardiac event, patient concern or other indicia, would be identified and centered on the x-axis in all three views.
- the placement of the temporal point of reference in the middle of all three x-axes enables the ECG data to be temporally keyed to the R-R interval data appearing in the center 60 of the R-R interval data view 53, with a near field view 51 of an ECG displayed at normal (paper-based) recording speed and a far field view 52 that presents the ECG data occurring before and after the center 60.
- the near field view 51 provides the ECG data corresponding to the R-R interval data at the center 60 (or other location) in a format that is familiar to all physicians, while the intermediate field view 52 enables presentation of the broader ECG data context going beyond the borders of the near field view 51.
- the center 60 can be slidably adjusted backwards and forwards in time, with the near field view 51 and the far field view 52 of the ECG data automatically adjusting accordingly to stay in context with the R-R interval data view 51.
- multiple temporal points of reference can be identified with each temporal point of reference being optionally accompanied by one or more dedicated sets of ECG data views.
- the collection of plots are conveniently arranged close enough to one another to facilitate printing on a single page of standard sized paper (or physical paper substitute, such as a PDF file), although other layouts of the plots are possible.
- the far field view 53 is plotted with time in the x-axis and heart rate in the_y-axis.
- the R-R intervals are calculated by measuring the time occurring between successive R-wave peaks.
- the far field view 53 presents R-R interval data (expressed as heart rate in bpm) that begins about 20 minutes prior to and ends about 20 minutes following the center 60, although other durations are possible.
- the near field view 51 and intermediate field view 52 present ECG data relative to the center 60 of the far field view 53.
- the near field view 51 provides a pinpoint or short duration view of the ECG data.
- the near field view 51 presents ECG data 55 that begins about two seconds prior to and ends about two seconds following the center 60, although other durations are possible.
- the intermediate field view 52 provides additional contextual ECG information allowing the physician to assess the ECG itself and gather a broader view of the rhythm before and after a "blow-up" of the specific arrhythmia of interest.
- the intermediate field view 52 presents ECG data 56 that begins about 12 seconds prior to and ends about 12 seconds following the center 60, although other durations are possible.
- the eight-second interval of the ECG data 56 in the intermediate field view 52 that makes up the ECG data 56 in the near field view 51 is visually highlighted, here, with a surrounding box 57.
- other views of the ECG data either in addition to or in lieu of the near field view 51 and the far field view 52 are possible.
- an ECG plot presenting an extended far field view 54 of the background information can be included in the diagnostic composite plot 50.
- the background information is presented as average heart rate with day and night periods 58 alternately shaded along the x-axis.
- Other types of background information such as activity amount, activity intensity, posture, syncope impulse detection, respiratory rate, blood pressure, oxygen saturation (Sp0 2 ), blood carbon dioxide level (pC0 2 ), glucose, lung wetness, and temperature, are possible.
- FIGURE 7 is a diagram showing, by way of example, a diagnostic composite plot 70 for facilitating the diagnosis of sinus rhythm (SR) transitioning into AF.
- SR sinus rhythm
- SR is indicated through the presence of a reasonably steady baseline, but with subsidiary lines of premature beats and their compensatory pauses.
- SR manifests as a shadowing 71 of a high heart rate line and a low heart rate line.
- AF is characterized by irregular heartbeats with a somewhat random variation of R-R intervals, although within a limited range and concentrating in a Gaussian-like distribution pattern around a mean that varies over time.
- AF can be diagnosed by viewing a near field view 51 of ECG data showing heartbeats with reversed P-wave and irregular R-R intervals, this approach may be unclear when viewing "snippets" of ECG data, especially when associated with poor quality ECG signals.
- the presence of AF can also be confirmed through a far field view 53 of R-R interval data, in which the R-R intervals assume superficially appearing disorganized, spread- out and decentralized scattered cloud 72 along the x-axis, in comparison to a concentrated, darkened line typical of a more organized cardiac rhythm.
- FIGURE 8 is a diagram showing, by way of example, a diagnostic composite plot 80 for facilitating the diagnosis of 3 : 1 atrial flutter (AFL) transitioning into SR with frequent premature ectopic atrial beats.
- the R-R intervals In the initial part of the R-R interval plot, the R-R intervals have a discernible aggregated line in the middle of the cloud 81 when the rhythm has yet to stabilize into a set pattern, not quite AF and not quite AFL.
- a dense line representing firm 3 : 1 atrial flutter stabilizes the rhythm prior to the transition into SR associated with the presence of two seesawing baselines that result from frequent atrial ectopy causing short coupling intervals and then compensatory long coupling intervals.
- SR is indicated by the middle of the three lines with a low heart rate line consistent with the compensatory pause (long coupling interval) and a high heart rate line with the shortest coupling interval representing the series of atrial premature beats 82, and thus, at a faster heart rate.
- FIGURE 9 is a diagram showing, by way of example, a diagnostic composite plot 90 for facilitating the diagnosis of atrial trigeminy.
- Atrial trigeminy is characterized by three heartbeat rates appearing intermittently yet reasonably regularly.
- atrial trigeminy can be diagnosed by viewing a near field view 51 of ECG data, the pattern is significantly more recognizable in a far field view 53 of R-R interval data, in which a repeating pattern of three distinct heartbeat lines are persistently present and clearly visible 91.
- This view also provides the physician with a qualitative feel for the frequency of the event troubling the patient that is not discernible from a single ECG strip.
- FIGURE 10 is a diagram showing, by way of example, a diagnostic composite plot 100 for facilitating the diagnosis of maximum heart rate in an episode of AF during exercise.
- AF manifests through a dispersed cloud of dots
- Heartbeat can be located by an increase in heart rate clustered about the cloud 102.
- individual dots above the 200 bpm range throughout the entire 40-minute range indicates the maximum heart rate during exercise.
- the very rapid rise in heart rate can be critical to patient management, as such bumps in rate by exercise can prove serious and even trigger cardiac arrest. Their very presence is easily visualized in the R-R interval data plot, thereby allowing the physician to alter therapy sufficiently to control such potentially damaging rises in heart rate.
- FIGURE 11 is a diagram showing, by way of example, a diagnostic composite plot 110 for facilitating the diagnosis of SR transitioning into AFL transitioning into AF.
- SR manifests as an uneven main heart rate line with a fluctuating height 111.
- the main heart rate line breaks away at a lower heart rate than the SR main heart rate line 112.
- the episode of AFL further evolves into AF as characterized by a dispersed cloud of irregular heartbeats without concentrated heart rate lines 113.
- This view provides critical information to the physician managing AF patients in that, at a glance, the view provides data that tells the physician that the patient's AF may be the consequence of AFL. Such knowledge may alter both drug and procedure therapies, like catheter ablation details of intervention.
- FIGURE 12 is a diagram showing, by way of example, a diagnostic composite plot 120 for facilitating the diagnosis of sinus tachycardia and palpitations that occurred during exercise accompanied by a jump in heart rate.
- sinus tachycardia is indicated by the presence of a baseline heart rate of about 60 bpm 121 that spikes up to around 100 bpm 122 and gradually slopes down with a wide tail 123, reflecting a sharp rise of heart rates followed by a gradual decline.
- the associated ECG data in the near field and intermediate field views can confirm the rhythm as sinus rhythm and a normal response to exercise.
- FIGURE 13 is a diagram showing, by way of example, a diagnostic composite plot 90 for facilitating the diagnosis of bradycardia during sleep and a R-R interval pattern
- bradycardia refers to a resting heart rate of under 60 bpm. Bradycardia during sleep is often tempered with occasional spikes of rapid heart rate, which can be a secondary compensatory response to dreaming, snoring or sleep apnea. In a far field view 50 of R-R interval data, bradycardia manifests as the presence of a base line heart rate in the range of about 50 bpm 131, coupled with multiple spikes of dots 132 representing intermittent episodes of elevated heart rate. Such elevations in heart rate during a pre-dominantly slower rate may be signs of a cardio-respiratory disorder. Still other applications of the diagnostic composite plot 80 are possible.
- FIGURE 14 is a block diagram showing a system 140 for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer 150 in accordance with one embodiment.
- Each diagnostic composite plot 151 is based on ECG data 166 that has either been recorded by a conventional electrocardiograph (not shown) or retrieved or obtained from some other type of ECG monitoring and recording device. Following completion of the ECG monitoring, the ECG data is assembled into a diagnostic composite plot 151, which can be used by a physician to diagnosis and, if required, treat a cardiac rhythm disorder, or for other health care or related purposes.
- Each diagnostic composite plot 151 is based on ECG data 166 that has been recorded over a period of observation, which can be for just a short term, such as during a clinic appointment, or over an extended time frame of months.
- ECG recordation and, in some cases, physiological monitoring can be provided through various types of ECG-capable monitoring ensembles, including a standardized 12-lead ECG setup (not shown), such as used for clinical ECG monitoring, a portable Holter-type ECG recorder for traditional ambulatory ECG monitoring (also not shown), or a wearable ambulatory ECG monitor.
- One form of ambulatory ECG monitor 142 particularly suited to monitoring and recording ECG and physiological data employs an electrode patch 143 and a removable reusable (or single use) monitor recorder 144, such as described in commonly-assigned U.S. Patent application, Serial No. 14/997,416, cited supra.
- the electrode patch 143 and monitor recorder 144 are synergistically optimized to capture electrical signals from the propagation of low amplitude, relatively low frequency content cardiac action potentials, particularly the P- waves generated during atrial activation.
- the ECG monitor 142 sits centrally (in the midline) on the patient's chest along the sternum 169 oriented top -to-bottom.
- the ECG monitor 142 interfaces to a pair of cutaneous electrodes (not shown) on the electrode patch 143 that are adhered to the patient's skin along the sternal midline (or immediately to either side of the sternum 169).
- the ECG monitor 142 has a unique narrow "hourglass" -like shape that significantly improves the ability of the monitor to be comfortably worn by the patient 141 for an extended period of time and to cutaneously sense cardiac electric signals, particularly the P- wave (or atrial activity) and, to a lesser extent, the QRS interval signals in the ECG waveforms indicating ventricular activity.
- the electrode patch 143 itself is shaped to conform to the contours of the patient's chest approximately centered on the sternal midline. To counter the dislodgment due to
- a layer of non-irritating adhesive such as hydrocolloid, is provided at least partially on the underside, or contact, surface of the electrode patch, but only on the electrode patch's distal and proximal ends.
- a strain relief is defined in the electrode patch's flexible circuit using cutouts partially extending transversely from each opposite side of the flexible circuit and continuing longitudinally towards each other to define in ' S'-shaped pattern.
- the electrode patch 143 is made from a type of stretchable spunlace fabric.
- the outward-facing aspect of the backing to which a (non-stretchable) flexible circuit is fixedly attached, stretches at a different rate than the backing's skin-facing aspect, where a skin adhesive removably affixes the electrode patch 143 to the skin.
- a skin adhesive removably affixes the electrode patch 143 to the skin.
- the monitor recorder 142 senses and records the patient's
- ECG data 166 and physiological data into a memory onboard the monitor recorder 144.
- the recorded data can be downloaded using a download station 147, which could be a dedicated download station 145 that permits the retrieval of stored ECG data 166 and physiological data, if applicable, execution of diagnostics on or programming of the monitor recorder 144, or performance of other functions.
- the monitor recorder 144 has a set of electrical contacts (not shown) that enable the monitor recorder 144 to physically interface to a set of terminals 148.
- the download station 145 can be operated through user controls 149 to execute a communications or data download program 146 ("Download") or similar program that interacts with the monitor recorder 144 via the physical interface to retrieve the stored ECG data 166.
- the download station 145 could alternatively be a server, personal computer, tablet or handheld computer, smart mobile device, or purpose-built device designed specific to the task of interfacing with a monitor recorder 144. Still other forms of download station 145 are possible.
- the ECG data 166 from the monitor recorder 144 can be offloaded wirelessly.
- the ECG data 166 can be retrieved from the download station 145 using a control program 157 ("Ctl") or analogous application executing on a personal digital computer 156 or other connectable computing device, via a hard wired link 158, wireless link (not shown), or by physical transfer of storage media (not shown).
- the personal digital computer 156 may also execute middleware (not shown) that converts the ECG data 166 into a format suitable for use by a third-party post-monitoring analysis program.
- the personal digital computer 156 stores the ECG data 166 along with each patient's electronic medical records (EMRs) 165 in the secure database 64, as further discussed infra.
- the download station 145 is able to directly interface with other devices over a computer communications network 155, which could be a combination of local area and wide area networks, including the Internet or another telecommunications network, over wired or wireless connections.
- a client-server model can be employed for ECG data 166 analysis.
- a server 62 executes a patient management program 160 ("Mgt") or similar application that accesses the retrieved ECG data 166 and other information in the secure database 164 cataloged with each patient's EMRs 165.
- the patients' EMRs can be supplemented with other information (not shown), such as medical history, testing results, and so forth, which can be factored into automated diagnosis and treatment.
- the patient management program 160, or other trusted application also maintains and safeguards the secure database 164 to limit access to patient EMRs 165 to only authorized parties for appropriate medical or other uses, such as mandated by state or federal law, such as under the Health Insurance Portability and
- HIPAA Health Insurance Portability Act
- European Union's Data Protection Directive Per the European Union's Data Protection Directive.
- Other schemes and safeguards to protect and maintain the integrity of patient EMRs 165 are possible.
- the wearable monitor 142 can interoperate wirelessly with other wearable or implantable physiology monitors and activity sensors 152, such as activity trackers worn on the wrist or body, and with mobile devices 153, including smart watches and smartphones.
- Wearable or implantable physiology monitors and activity sensors 152 encompass a wide range of wirelessly interconnectable devices that measure or monitor a patient's physiological data, such as heart rate, temperature, blood pressure, respiratory rate, blood pressure, blood sugar (with or without an appropriate subcutaneous probe), oxygen saturation, minute ventilation, and so on; physical states, such as movement, sleep, footsteps, and the like; and performance, including calories burned or estimated blood glucose level.
- wearable and implantable physiology monitors and activity sensors 152 are capable of wirelessly interfacing with mobile devices 153, particularly smart mobile devices, including so-called “smartphones” and “smart watches,” as well as with personal computers and tablet or handheld computers, to download monitoring data either in real-time or in batches through an application (“App”) or similar program.
- mobile devices 153 particularly smart mobile devices, including so-called “smartphones” and “smart watches,” as well as with personal computers and tablet or handheld computers, to download monitoring data either in real-time or in batches through an application (“App”) or similar program.
- App application
- ECG data 166 Based on the ECG data 166, physicians can rely on the data as medically certifiable and are able to directly proceed with diagnosing cardiac rhythm disorders and determining the appropriate course of treatment for the patient 141, including undertaking further medical interventions as appropriate.
- the ECG data 166 can be retrieved by a digital computer 150 over the network 155.
- a diagnostic composite plot 151 that includes multiple temporal points of reference and a plot of R-R interval data is then constructed based on the ECG data 166, as discussed in detail supra with reference to FIGURE 3, and displayed or, alternatively, printed, for use by a physician.
- the server 159 executes a patient diagnosis program 161 ("Dx") or similar application that can evaluate the ECG data 166 to form a diagnosis of a cardiac rhythm disorder.
- the patient diagnosis program 161 compares and evaluates the ECG data 166 to a set of medical diagnostic criteria 167, from which a diagnostic overread 162 ("diagnosis”) is generated.
- Each diagnostic overread 162 can include one or more diagnostic findings 168 that can be rated by degree of severity, such as with the automated diagnosis of atrial fibrillation.
- diagnostic findings 168 for a patient exceed a threshold level of tolerance, which may be tailored to a specific client, disease or medical condition group, or applied to a general patient population, in a still further embodiment, therapeutic treatment ("Therapy") to address diagnosed disorder findings can be generated and, optionally, programmed into a cardiac rhythm therapy delivery device, such as an IMD (not shown), including a pacemaker, implantable cardioverter defibrillator (ICD), or similar devices.
- IMD implantable cardioverter defibrillator
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562132497P | 2015-03-12 | 2015-03-12 | |
US14/997,416 US9345414B1 (en) | 2013-09-25 | 2016-01-15 | Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer |
US15/066,883 US9408551B2 (en) | 2013-11-14 | 2016-03-10 | System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer |
PCT/US2016/022154 WO2016145392A1 (fr) | 2015-03-12 | 2016-03-11 | Agencement d'affichage pour le diagnostic de troubles de rythme cardiaque |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3267881A1 true EP3267881A1 (fr) | 2018-01-17 |
Family
ID=55640894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16712606.9A Ceased EP3267881A1 (fr) | 2015-03-12 | 2016-03-11 | Agencement d'affichage pour le diagnostic de troubles de rythme cardiaque |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3267881A1 (fr) |
CA (1) | CA2978636C (fr) |
WO (1) | WO2016145392A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10758139B2 (en) | 2015-10-27 | 2020-09-01 | Cardiologs Technologies Sas | Automatic method to delineate or categorize an electrocardiogram |
US11147500B2 (en) | 2015-10-27 | 2021-10-19 | Cardiologs Technologies Sas | Electrocardiogram processing system for delineation and classification |
US11331034B2 (en) | 2015-10-27 | 2022-05-17 | Cardiologs Technologies Sas | Automatic method to delineate or categorize an electrocardiogram |
US11672464B2 (en) | 2015-10-27 | 2023-06-13 | Cardiologs Technologies Sas | Electrocardiogram processing system for delineation and classification |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10827938B2 (en) | 2018-03-30 | 2020-11-10 | Cardiologs Technologies Sas | Systems and methods for digitizing electrocardiograms |
AU2018320182B2 (en) * | 2017-08-25 | 2023-11-30 | Koninklijke Philips N.V. | User interface for analysis of electrocardiograms |
CN109567790A (zh) * | 2018-12-24 | 2019-04-05 | 深圳市瑞康宏业科技开发有限公司 | 一种心电散点图快速局部分析方法、装置和计算机装置 |
CN116322479A (zh) | 2020-08-10 | 2023-06-23 | 心道乐科技股份有限公司 | 用于检测和/或预测心脏事件的心电图处理系统 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06319711A (ja) * | 1993-05-13 | 1994-11-22 | Sharp Corp | 携帯型心電計 |
JP2004129788A (ja) * | 2002-10-09 | 2004-04-30 | Nippon Koden Corp | 生体情報処理装置 |
JP2005000409A (ja) * | 2003-06-12 | 2005-01-06 | Omron Healthcare Co Ltd | 心電計および心電波形表示方法 |
US20100280366A1 (en) * | 2008-05-13 | 2010-11-04 | Lawrence Arne | Continuous field tomography systems and methods of using the same |
-
2016
- 2016-03-11 CA CA2978636A patent/CA2978636C/fr active Active
- 2016-03-11 EP EP16712606.9A patent/EP3267881A1/fr not_active Ceased
- 2016-03-11 WO PCT/US2016/022154 patent/WO2016145392A1/fr active Application Filing
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10758139B2 (en) | 2015-10-27 | 2020-09-01 | Cardiologs Technologies Sas | Automatic method to delineate or categorize an electrocardiogram |
US11147500B2 (en) | 2015-10-27 | 2021-10-19 | Cardiologs Technologies Sas | Electrocardiogram processing system for delineation and classification |
US11331034B2 (en) | 2015-10-27 | 2022-05-17 | Cardiologs Technologies Sas | Automatic method to delineate or categorize an electrocardiogram |
US11672464B2 (en) | 2015-10-27 | 2023-06-13 | Cardiologs Technologies Sas | Electrocardiogram processing system for delineation and classification |
Also Published As
Publication number | Publication date |
---|---|
CA2978636A1 (fr) | 2016-09-15 |
CA2978636C (fr) | 2021-05-11 |
WO2016145392A1 (fr) | 2016-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11647939B2 (en) | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer | |
US11826151B2 (en) | System and method for physiological data classification for use in facilitating diagnosis | |
US11653870B2 (en) | System and method for display of subcutaneous cardiac monitoring data | |
US11647941B2 (en) | System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer | |
CA2978636C (fr) | Agencement d'affichage pour le diagnostic de troubles de rythme cardiaque | |
US9538933B2 (en) | QT interval monitoring system with alarms and trending | |
Kligfield et al. | Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society endorsed by the International Society for Computerized Electrocardiology | |
US20100204552A1 (en) | Apparatus for monitoring biological information | |
US20240112800A1 (en) | System and method for long-term patient monitoring of continuous ecg and physiological data | |
EP3488772B1 (fr) | Classification de données d'ecg pour faciliter le diagnostic de troubles du rythme cardiaque à l'aide d'un ordinateur numérique | |
CA3146940A1 (fr) | Facilitation du diagnostic d'un trouble du rythme cardiaque a l'aide d'un ordinateur numerique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20171005 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20181017 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20210731 |